ZAPPAVIGNA, Silvia
 Distribuzione geografica
Continente #
EU - Europa 7.864
NA - Nord America 4.892
AS - Asia 3.122
Continente sconosciuto - Info sul continente non disponibili 387
SA - Sud America 385
AF - Africa 55
OC - Oceania 10
Totale 16.715
Nazione #
RU - Federazione Russa 5.036
US - Stati Uniti d'America 4.814
SG - Singapore 1.060
IE - Irlanda 801
IT - Italia 742
CN - Cina 684
VN - Vietnam 445
HK - Hong Kong 364
BR - Brasile 330
GB - Regno Unito 265
DE - Germania 240
UA - Ucraina 230
KR - Corea 187
FR - Francia 138
IN - India 96
SE - Svezia 92
FI - Finlandia 88
JP - Giappone 74
GR - Grecia 72
TR - Turchia 54
CA - Canada 40
BD - Bangladesh 36
PL - Polonia 27
PK - Pakistan 24
AR - Argentina 23
BG - Bulgaria 23
NL - Olanda 23
BE - Belgio 21
ZA - Sudafrica 21
AT - Austria 20
MX - Messico 20
ID - Indonesia 17
ES - Italia 16
CO - Colombia 12
MA - Marocco 12
UZ - Uzbekistan 12
IQ - Iraq 11
EC - Ecuador 10
IR - Iran 10
AU - Australia 8
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
KE - Kenya 5
AZ - Azerbaigian 4
DZ - Algeria 4
EE - Estonia 4
EU - Europa 4
LT - Lituania 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
CH - Svizzera 3
CL - Cile 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
VE - Venezuela 3
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 16.332
Città #
Moscow 1.772
San Jose 815
Dublin 801
Chandler 517
Singapore 496
Santa Clara 476
Jacksonville 363
Hong Kong 360
Council Bluffs 262
Dallas 202
Ashburn 199
Seoul 176
Ho Chi Minh City 127
Naples 120
Hefei 117
New York 115
Beijing 99
Caserta 98
Princeton 96
Hanoi 90
Roxbury 83
Medford 73
Los Angeles 70
Bengaluru 62
Boardman 59
Bremen 58
Ann Arbor 54
Dong Ket 54
The Dalles 43
Munich 39
Des Moines 36
Cambridge 34
Wilmington 33
Aversa 31
Napoli 31
São Paulo 30
Helsinki 27
Orem 26
Milan 25
Nuremberg 25
Woodbridge 25
Mountain View 24
Rome 23
Da Nang 22
San Mateo 22
Brussels 20
Haiphong 19
Warsaw 17
Johannesburg 14
Frankfurt am Main 13
London 13
Phoenix 13
Mexico City 12
Rio de Janeiro 12
Amsterdam 11
Campodarsego 11
Tashkent 11
Tokyo 11
Atlanta 10
Guangzhou 10
Istanbul 10
Madrid 10
San Nicola la Strada 10
Chicago 9
Columbus 9
Denver 9
Falkenstein 9
Houston 9
Jinan 9
Kochi 9
Memphis 9
Piscataway 9
San Felice A Cancello 9
Vienna 9
Biên Hòa 8
Boston 8
Brasília 8
Brooklyn 8
Jakarta 8
San Francisco 8
Thái Nguyên 8
Changsha 7
Curitiba 7
Düsseldorf 7
Elora 7
Hillsboro 7
Nanjing 7
Philadelphia 7
Redwood City 7
Tianjin 7
Xi'an 7
Bologna 6
Cagliari 6
Lissone 6
Montreal 6
Ningbo 6
Ninh Bình 6
Norwalk 6
Seregno 6
Stockholm 6
Totale 8.816
Nome #
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 231
Mitochondria as playmakers of apoptosis, autophagy and senescence 208
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 203
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 203
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 202
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 199
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 195
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 194
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 192
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 192
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 191
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 189
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 188
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 187
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 184
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 183
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 183
Anti-inflammatory drugs as anticancer agents 182
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 181
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 178
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 178
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 176
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 176
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 173
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 167
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 167
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 165
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 165
Immune cell infiltration and inflammatory landscape in primary brain tumours 164
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 161
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 158
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 158
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 158
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 157
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 156
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 155
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide 154
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 152
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 150
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 150
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 150
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 148
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 148
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 148
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 148
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 147
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 146
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 144
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 143
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 142
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 142
The role of micrornas in development of colitis-associated colorectal cancer 142
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 141
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 140
Emerging pathways as individualized therapeutic target of multiple myeloma. 136
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 135
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 135
Poly(ε-caprolactone)-poly(ethylene glycol) Tri-Block Copolymer as Quercetin Delivery System for Human Colorectal Carcinoma Cells: Synthesis, Characterization and In Vitro Study 135
Autophagic cell death: A new frontier in cancer research 134
Characterization of KRAS Mutational Regression in Oligometastatic Patients 133
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 132
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 131
Measurement of autophagy by flow cytometry 131
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 131
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 130
Interleukin 18: Friend or foe in cancer. 130
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 130
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 129
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 129
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 129
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 129
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 128
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 127
Evolutionary conservation of a regulative pathway of erythropoiesis in Poikilothermic vertebrates 126
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 126
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 124
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 124
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 123
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 123
Long non-coding RNAs in cancer stem cells 122
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use 120
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 120
Testicular cancer from diagnosis to epigenetic factors 118
Erlotinib: early clinical development in brain cancer. 116
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer 116
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 114
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 113
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 112
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 112
Protein kinase a detection in human urine samples 112
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 111
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 111
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 111
Hepatocarcinoma: genetic and epigenetic features 109
Ipilimumab for the treatment of metastatic prostate cancer 106
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 104
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 104
Non-coding RNAs as a new dawn in tumor diagnosis 103
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 103
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 100
Totale 14.711
Categoria #
all - tutte 56.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 0 0 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/20251.914 17 46 8 99 287 301 233 178 285 185 158 117
2025/20268.975 341 441 550 337 694 4.661 564 630 238 235 186 98
2026/2027795 64 179 552 0 0 0 0 0 0 0 0 0
Totale 16.715